|
DUSP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.941400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.726200E-01 |
| Normal-vs-Stage2 |
7.961400E-01 |
| Normal-vs-Stage3 |
3.225600E-01 |
| Normal-vs-Stage4 |
4.142000E-01 |
| Stage1-vs-Stage2 |
7.467800E-01 |
| Stage1-vs-Stage3 |
2.844600E-01 |
| Stage1-vs-Stage4 |
4.372200E-01 |
| Stage2-vs-Stage3 |
5.955800E-01 |
| Stage2-vs-Stage4 |
8.288400E-01 |
| Stage3-vs-Stage4 |
6.657400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.467000E-01 |
| Normal-vs-AfricanAmerican |
3.813200E-01 |
| Normal-vs-Asian |
5.859400E-01 |
| Caucasian-vs-AfricanAmerican |
2.473200E-01 |
| Caucasian-vs-Asian |
7.622800E-01 |
| AfricanAmerican-vs-Asian |
1.871430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.373800E-01 |
| Normal-vs-Female |
2.077800E-01 |
| Male-vs-Female |
4.824100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.288600E-01 |
| Normal-vs-Extreme_Weight |
2.099800E-01 |
| Normal-vs-Obese |
5.420800E-01 |
| Normal-vs-Extreme_Obese |
9.981600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.843600E-02 |
| Normal_Weight-vs-Obese |
6.372800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.515600E-02 |
| Extreme_Weight-vs-Obese |
1.150780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.930400E-01 |
| Obese-vs-Extreme_Obese |
6.117700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.854300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.102400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.239600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.139400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.664300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.885900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.613700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.949200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.938400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.695000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.092600E-01 |
| Normal-VS-Type2 PRCC |
3.686400E-01 |
| Normal-VS-KIRP CIMP |
1.891680E-02 |
| Normal-VS-Unclassified PRCC |
2.776400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.245400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.573840E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.443510E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.552050E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.893750E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.174450E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.890200E-01 |
| Normal-vs-N1 |
2.143600E-01 |
| Normal-vs-N2 |
4.168200E-01 |
| N0-vs-N1 |
1.542410E-01 |
| N0-vs-N2 |
4.938400E-01 |
| N1-vs-N2 |
7.974800E-01 |
|
|
